Clinical trials are the most costly, time-consuming, and heavily regulated stages in drug development, often costing hundreds of millions of dollars and sometimes exceeding a billion dollars. Every month of delay cuts into the patent-protected window that determines a drug’s commercial viability, with companies losing tens of millions of dollars
People are starting to compile resolutions for the new year, focusing on evolving their own habits and goals. At SAS, we’ve also looked toward 2026 to gather predictions on how AI in the public sector might evolve over the next 12 months. Prediction: By 2026, governments will utilize large language
For years, “responsible AI” has lived comfortably as a corporate promise, a slide in a presentation, a talking point at a conference. But as the EU AI Act phases into force, that comfort is rapidly eroding. The regulation officially entered into force on August 1, 2024, but its obligations will
